Dana-Farber Cancer Institute /ID# 162675

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Myelofibrosis (MF)

Studies at this site

• A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With Myelofibrosis — Completed